Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

Background. Concomitant use of rifamycins to treat or prevent tuberculosis can result in subtherapeutic concentrations of antiretroviral drugs. We studied the interaction of efavirenz with daily rifapentine and isoniazid in human immunodeficiency virus (HIV)–infected individuals receiving a 4-week r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Podany, Anthony T., Bao, Yajing, Swindells, Susan, Chaisson, Richard E., Andersen, Janet W., Mwelase, Thando, Supparatpinyo, Khuanchai, Mohapi, Lerato, Gupta, Amita, Benson, Constance A., Kim, Peter, Fletcher, Courtney V.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583578/
https://ncbi.nlm.nih.gov/pubmed/26082504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados